New York, December 2025 – New York-founded recruitment firm Metric is proud to announce the successful placement of Jeffrey Mason as Vice President of Sales, America at Samsung Biologics. As one of the world’s foremost CDMOs, Samsung Biologics delivers integrated biologics development and manufacturing services to biopharma partners across the globe, with capabilities spanning the full development lifecycle from cell line development through to commercial-scale CGMP manufacturing and aseptic fill/finish.
The search was led by Sam McElroy, Director at Metric Bio.
Reflecting on the process, Jeffrey Mason commented: “I worked with Sam recently, and it was a very positive experience, with him placing me in my newest role. He was professional, attentive, and responsive throughout. I would definitely work with him again and would recommend reaching out to him if a vacancy requires filling.”
Speaking of the placement, Sam McElroy commented: “Our partnership with Samsung Biologics is one we value enormously, and placing Jeff as leader of the Samsung Biologics America sales function is a reflection of the trust they place in us to understand their business and find the right people. Identifying commercial talent capable of leading such a high-performance team demands genuine CDMO industry knowledge, and Jeff brings exactly the reputation and caliber of experience this role requires.”
About Metric
Metric is a New York-founded executive and specialty recruitment firm, recognized by the Financial Times as one of the fastest growing companies. Partnering with some of the world’s most innovative businesses, Metric builds high-performing global teams across Life Sciences, Infrastructure, Engineering and Data Centers.
Through Metric Exec, the firm delivers C-suite and board-level appointments across its sectors, from high-growth businesses to investor-backed portfolios. Metric is backed by Southfield Capital and operates from seven offices across the US and UK.
